by In2Pharma | Jan 8, 2025 | News
Belgium Companies with a GDP-certificate with validity date end December 2024, should have received – addressed to their RP – a communication from the FAMHP with regard to the GDP-certificate expiring in December 2024. In parallel, the below...
by In2Pharma | Oct 27, 2023 | News
Belgium On 16 October, the Belgian federal agency for medicines and health products (FAMHP) has introduced a new application for the effective management of marketing authorisation and vigilance dossiers. Data Tracking System (DTS) will replace 4 MeSeA applications:...
by In2Pharma | Sep 29, 2023 | News
Belgium The Belgian “National Medicines Verification System” (NMVS) is linked to the “European Alert Management System” (EAMS) via a “National Alert Management System” (NAMS) since 1 July 2023. Since there is now the possibility of...
by In2Pharma | Aug 4, 2023 | News
Belgium The FAMHP will open a new web portal later this year for manufacturers based in Belgium who are subject to inspections in the context of a GMP certificate, manufacturing and import authorization (MIA), raw materials (AR 97), active ingredients (API) or...
by In2Pharma | Aug 3, 2023 | News
Belgium The Belgian government has issued a royal decree (19 January 2023) allowing the export of medicines to be temporarily restricted. The decree allows an export in case of unavailability to be subject to prior authorisation, if it concerns essential medicines and...
